CA
NZ
UK
AU
IND
US
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,250,000 shares of Aspen Neuroscience Inc. common stock as of October 30, 2026.
FMR LLC filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing a 15.0% beneficial ownership position in Tango Therapeutics Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 9,514,519 shares of Strive Inc Class A Common Stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Sprouts Farmers Market Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of common stock in City Therapeutics Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Upstream Bio Inc as of October 30, 2026.
Iron Mountain Inc. officer and director William L. Meaney filed a Form 144 notice of proposed sale on November 6, 2026, covering 38,474 shares of Iron Mountain common stock acquired through a stock option exercise.
Director Sue Gove filed a Form 4 with the SEC on November 6, 2026, disclosing a purchase of LKQ Corp common stock on November 4, 2026.
Davis Selected Advisers filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 52,234,136 shares of JBS N.V. common stock as of September 30, 2026.
Teladoc Health, Inc. officer Carlos Nueno filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 29,432 shares of Teladoc Health common stock with an aggregate market value of $270,774.40.
Please wait processing your request...